Form 8-K - Current report:
SEC Accession No. 0001493152-20-018628
Filing Date
2020-09-30
Accepted
2020-09-30 16:46:19
Documents
12
Period of Report
2020-09-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34056
  Complete submission text file 0001493152-20-018628.txt   212420

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hrow-20200928.xsd EX-101.SCH 3189
3 XBRL LABEL FILE hrow-20200928_lab.xml EX-101.LAB 35273
4 XBRL PRESENTATION FILE hrow-20200928_pre.xml EX-101.PRE 23148
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3776
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 201212773
SIC: 2834 Pharmaceutical Preparations